Title
Genentech: The Beginnings of Biotech (Synthesis),Used
Sold by Ergodebooks, an authorized reseller.
Returns accepted within 30 days | support@ergodebooks.com
Shipping Information
- Free Standard Shipping — United States only
- Processing Time: 3–5 business days
- Estimated Delivery: 6–10 business days after dispatch
- Double-boxed, fully insured & discreetly packaged
- Tracking number sent via email once dispatched
Returns & Refund
Returns accepted within 30 days of delivery.
Damaged or Defective Item
Free return shipping + replacement or full refund
Wrong Item Received
Free return shipping + replacement or full refund
Change of Mind
Return shipping at customer's expense · 25% restocking fee applies
Payment Option
In the fall of 1980, Genentech, Inc., a littleknown California genetic engineering company, became the overnight darling of Wall Street, raising over $38 million in its initial public stock offering. Lacking marketed products or substantial profit, the firm nonetheless saw its share price escalate from $35 to $89 in the first few minutes of trading, at that point the largest gain in stock market history. Coming at a time of economic recession and declining technological competitiveness in the United States, the event provoked banner headlines and ignited a period of speculative frenzy over biotechnology as a revolutionary means for creating new and better kinds of pharmaceuticals, untold profit, and a possible solution to national economic malaise.Drawing from an unparalleled collection of interviews with early biotech players, Sally Smith Hughes offers the first booklength history of this pioneering company, depicting Genentechs improbable creation, precarious youth, and ascent to immense prosperity. Hughes provides intimate portraits of the people significant to Genentechs science and business, including cofounders Herbert Boyer and Robert Swanson, and in doing so sheds new light on how personality affects the growth of science. By placing Genentechs founders, followers, opponents, victims, and beneficiaries in context, Hughes also demonstrates how science interacts with commercial and legal interests and university research, and with government regulation, venture capital, and commercial profits.Integrating the scientific, the corporate, the contextual, and the personal, Genentech tells the story of biotechnology as it is not often told, as a risky and improbable entrepreneurial venture that had to overcome a number of powerful forces working against it.
⚠️ WARNING (California Proposition 65):
This product may contain chemicals known to the State of California to cause cancer, birth defects, or other reproductive harm.
For more information, please visit www.P65Warnings.ca.gov.
- Q: What is the main topic of 'Genentech: The Beginnings of Biotech'? A: The book explores the history of Genentech, Inc., detailing its rise as a pioneering company in the biotechnology sector, focusing on its creation, early challenges, and eventual success.
- Q: Who is the author of this book? A: The author is Sally Smith Hughes, who provides in-depth insights based on interviews with key figures in the biotech industry.
- Q: What type of condition is the book in? A: The book is listed as 'Used Book in Good Condition', meaning it has been previously owned but is still in a satisfactory state for reading.
- Q: When was 'Genentech: The Beginnings of Biotech' published? A: The book was published on April 8, 2013.
- Q: What is the page count of the book? A: The book contains a total of 232 pages.
- Q: What format is the book available in? A: The book is available in paperback format.
- Q: What subjects does the book cover? A: The book covers subjects related to company profiles, biotechnology history, and the interplay between science and commercial interests.
- Q: Is this book suitable for someone interested in biotechnology? A: Yes, the book is suitable for anyone interested in biotechnology, its history, and the entrepreneurial aspects of the industry.
- Q: Are there any notable figures featured in the book? A: Yes, the book features notable figures such as cofounders Herbert Boyer and Robert Swanson, along with others influential in Genentech's story.
- Q: What is the significance of Genentech's IPO mentioned in the book? A: Genentech's IPO in 1980 was significant as it raised over $38 million and marked a pivotal moment in biotechnology, showcasing the potential for substantial profit in the sector.